|Creating the next generation of cancer treatments
September 1, 2015
Arno Therapeutics to Present at 17th Annual Rodman & Renshaw Conference
FLEMINGTON, NJ - September 1, 2015 - Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics, today announced that Alexander Zukiwski, Chief Executive Officer & Chief Medical Officer of Arno Therapeutics is scheduled to present at the 17th Annual Rodman & Renshaw Global Investment conference being held September 8-10, 2015 in New York, NY.
Details of the presentations are as follows:
Conference: Rodman & Renshaw Global Investment Conference
Date: Thursday, September 10th, 2015
Time: 1:45 p.m. ET
Room: Astor Suite A, Second Floor of the St. Regis Hotel, NYC
Investors attending the conferences who would like to schedule a 1-on-1 meeting with Arno Therapeutics’ management may do so by contacting their Rodman & Renshaw representatives, or Joseph Green at The Ruth Group at email@example.com.
About Arno Therapeutics
Arno Therapeutics is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer and other life threatening diseases. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information about the company, please visit www.arnothera.com.
The Ruth Group
Lee Roth (investors)
Kirsten Thomas (media)